BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds
AssigneeSouthwest Research Institute
InventorJorge Gianny ROSSINI
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a method to stimulate endogenous BMP-2 up-regulation in a subject which method comprises administering to a subject an effective amount of an H1 receptor antagonist, whereby endogenous BMP-2 up-regulation is stimulated in said subject. Also provided is a pharmaceutical formulation including an H1 receptor antagonist present in an effective amount to stimulate BMP-2 up-regulation in a subject and a kit.
Claims22
A method to stimulate endogenous BMP-2 up-regulation in a subject which method comprises administering to a subject an effective amount of an H1 receptor antagonist, whereby endogenous BMP-2 up-regulation is stimulated in said subject.
A pharmaceutical formulation for the delivery of an endogenous BMP-2 up-regulator, comprising:
- an H1 receptor antagonist present in an effective amount to stimulate BMP-2 up-regulation in a subject.
A kit comprising:
- a vessel containing a composition including from 0.02 mg/kg to 1,000 mg/kg an H1 receptor antagonist;
- and
- instructions for the administration of said H1 receptor antagonist to a subject in need thereof in an effective amount for endogenous BMP-2 upregulation.
Dependencies are inferred from the claim text.